Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Site News
Market: Market:

Sernova Corp (SEOVF)

Sernova Corp (SEOVF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June Globe Newswire - Wed Jun 15, 6:00AM CDT

LONDON, Ontario, June 15, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in...

SVA.VN : 1.570 (+6.08%)
SVA.TO : 1.17 (-7.14%)
SEOVF : 0.9000 (-8.88%)
Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022 Globe Newswire - Mon Jun 6, 3:30PM CDT

Researchers from the Dr. Piotr Witkowski Laboratory at the University of Chicago presented updated data on six patients with type 1 diabetes and...

SVA.VN : 1.570 (+6.08%)
SVA.TO : 1.17 (-7.14%)
SEOVF : 0.9000 (-8.88%)
Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes Globe Newswire - Tue May 17, 6:00AM CDT

Partnership Leverages Sernova’s Proprietary Cell Pouch System™ with Evotec’s iPSC-Based Insulin-Producing Beta CellsPartners to Develop and Commercialize...

SVA.VN : 1.570 (+6.08%)
SEOVF : 0.9000 (-8.88%)
Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing Globe NewsWire - Mon Mar 29, 2021

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

OTCM : 54.7500 (-0.45%)
SEOVF : 0.9000 (-8.88%)
SHGFF : 5.6450 (+1.71%)
BABYF : 0.5600 (+0.90%)
CRTPF : 2.3000 (+5.50%)
VVIVF : 0.1559 (+7.37%)
AVCNF : 0.1900 (+2.98%)
ORXOY : 2.3000 (unch)
DOC.VN : 0.408 (+0.74%)
SVA.VN : 1.570 (+6.08%)
SHG.VN : 6.800 (+5.92%)
BABY.VN : 1.170 (unch)
Sernova to Webcast Live at Life Sciences Investor Forum March 25th Globe NewsWire - Mon Mar 22, 2021

Sernova invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

OTCM : 54.7500 (-0.45%)
SEOVF : 0.9000 (-8.88%)
SVA.VN : 1.570 (+6.08%)
Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021 Globe NewsWire - Fri Mar 19, 2021

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 54.7500 (-0.45%)
SEOVF : 0.9000 (-8.88%)
SHGFF : 5.6450 (+1.71%)
BABYF : 0.5600 (+0.90%)
XRTXF : 0.4387 (-1.50%)
CRTPF : 2.3000 (+5.50%)
VVIVF : 0.1559 (+7.37%)
AVCNF : 0.1900 (+2.98%)
ORXOY : 2.3000 (unch)
SVA.VN : 1.570 (+6.08%)
SHG.VN : 6.800 (+5.92%)
BABY.VN : 1.170 (unch)
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A Business Wire - Fri May 29, 2020

AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, and Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF)(FSE:PSH), a clinical-stage...

SVA.VN : 1.570 (+6.08%)
SEOVF : 0.9000 (-8.88%)
AGE : 0.5738 (-5.83%)

Barchart Exclusives

Microsoft Stock Offers a Great Value Equation Here Barchart - Sun Jun 26, 5:29PM CDT
Microsoft stock offers investors a great value equation here - a good yield, low P/E, earnings growth, and large buybacks equate to a higher price. Buying near-the-money calls are a good way to play it. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' : 'America/Chicago' ]] CDT
Reserve Your Spot